Private mufface or SS

Mutualista, many years already with private company.I think the decision is very conditioned by the area in which we live.Asisa, I am doing very well.The endocrine prescribes insulins, then on the day to day the head doctor intervenes.The rest of the material is provided by the company.
Perhaps the most angry is the visa of the Tresiba.Access to specialists, although it has worsened, especially in times, privately.

All the best.

If you are diabetic or have any disease, they do not make any private insurance.
It's like car insurance ...

juansolo said:
If you are diabetic or have any disease, they do not make any private insurance.
It's like car insurance ...

It is like that, as is, they would not do it to me

But those who have mutuality, yes

nila said:
but those who have mutuality, if

Until something fat passes and send them to the SS for lack of means or personnel

Well, I debuted in a Sanitas hospital, they have not yet thrown me but I do not spend, I just go to the gynecologist for Sanitas, once to the dermatologist and it is already in 15 years or more that I carry with them.

ruthbia said:
Well I debuted in a Sanitas hospital, they have not yet thrown me but I do not spend, I just go to the gynecologist for Sanitas, once to the dermatologist and it is already in 15 yearsor more than I carry with them.

Of course, but not because of the diabetes PQ between sensors, strips, insulins and several care, counting that there is nothing else, there are quite a few expenses.If you were already there before debuting, the same does not happen or you increase the price with the TPO, but you have the SS for diabetes theme, I mean having only the private one.If you do more than normal reviews, they will not tell you anything.

Muface is only for officials or children of officials, right?

I keep the summary that the AI ​​gives me.I would like your opinions because according to the AI, changing from SS to Muface or vice versa does not interrupt any of the supplies:

AI:

Yes, in practice MUFACE maintains the equipment (the insulin pump) and supplies (expendable material such as reservoirs, cannulas, infusion lines, etc.) in the same type and quantity as in the National Health System (SNS/Social Security)., because the coverage is based on the same basic regulations and on the common portfolio of SNS services.

TheOrder SCO/710/2004(which included the bombs in public financing) and theOrder APU/2245/2005(specific to MUFACE, with multiple updates until 2022 and no relevant changes reported in 2025) establish that MUFACE finances 100% of portable continuous subcutaneous insulin infusion pumps and their consumablesunder the same terms and conditionsthan in the SNS.This means:

• The bomb itself: It is delivered or financed directly (normally renewed every 4-6 years depending on wear and tear or model, the same as in SNS).If you already have one on SNS, moving to MUFACE authorizes the continuity of the same or equivalent model (at no additional cost to you).
• Supplies (expendable material): Reservoirs, infusers/cannulas, adapters, etc., are dispensed at the same frequency and quantity prescribed by the endocrinologist (for example, 10-12 reservoirs per month + cannulas according to use, according to standard clinical guidelines of the Spanish Diabetes Society).There is no systematic reduction;It is adjusted to the individual medical indication, just as in the SNS.
• Treatment continuity: When you register in MUFACE (and cancel in SNS), the specialist from your subsidized entity (Adeslas, ASISA, DKV, etc., or the public system if you choose that option) reviews your history and current prescription.Authorization for continuity is usually quick (days/weeks), andThey do not change the type or quantityunless the doctor considers clinical adjustments (the same would occur in SNS).

Minimal practical differences (not in quantity/type, but in management)

• InMUFACE with private entity(the most common option): Dispensing is usually more agile (you pick up at agreed centers or private pharmacies/hospitals), and sometimes there are more models of pumps available (Medtronic, Tandem, Omnipod, etc., depending on the agreement).
• InSNS: Dispensing in public hospitals, with possible waiting lists for reviews or model changes, but the prescribed quantity is identical.
• There is no co-payment on pumps or consumables in either system (100% financing for indicated).

In diabetes patient forums (such asDiabetesForum) and real experiences, people who switch from SNS to MUFACE report thatthey maintain exactly the same pump and the same supply schedule, without cuts.If there is any specific change, it is due to technological evolution or medical decision, not because of the system.

Conclusion to December 2025: There are no substantial differences in type or quantity;MUFACE is obliged to be comparable to the SNS to avoid inequalities (as established by regulations).If your case is specific (current pump model, CC.AA., entity), the ideal is to bring the latest endocrine report to MUFACE or your provincial office when processing discharge — they confirm immediate continuity.If any discrepancy arises (very rare), it is resolved by referring to the endocrinologist or MUFACE directly.